Exhibit 21

Subsidiaries

Name of Subsidiary	Jurisdiction of Incorporation or Organization	Percentage of Ownership by the Registrant
B10 Health Technologies Private Limited	India	100	%
BeiGene 101	Cayman Islands	100	%
BeiGene Argentina S.R.L.	Argentina	100	%
BeiGene AUS Pty Ltd	Australia	100	%
BeiGene Austria GmbH	Austria	100	%
BeiGene (Beijing) Co., Ltd.	People’s Republic of China	100	%
BeiGene Belgium SRL	Belgium	100	%
BeiGene Biologics Co., Ltd.	People’s Republic of China	100	%
BeiGene Brasil Ltda.	Brazil	100	%
BeiGene (Canada) ULC	Canada	100	%
BeiGene Chile Limitada	Chile	100	%
BeiGene Colombia S.A.S.	Colombia	100	%
BeiGene ESP, S.L.U. Unipersonal	Spain	100	%
BeiGene France Sarl	France	100	%
BeiGene Germany GmbH	Germany	100	%
BeiGene Guangzhou Biologics Manufacturing Co., Ltd.	People’s Republic of China	100	%
BeiGene (Guangzhou) Innovation Technology Co., Ltd.	People’s Republic of China	100	%
BeiGene (Hong Kong) Co., Limited	Hong Kong	100	%
BeiGene Hopewell Urban Renewal, LLC	New Jersey, United States	100	%
BeiGene International GmbH	Switzerland	100	%
BeiGene Ireland Limited	Republic of Ireland	100	%
BeiGene (Italy) S.r.l.	Italy	100	%
BeiGene Japan GK	Japan	100	%
BeiGene Korea Y.H.	South Korea	100	%
BeiGene Malaysia Sdn. Bhd.	Malaysia	100	%
BeiGene Mexico S. de R.L. de C.V.	Mexico	100	%
BeiGene Netherlands B.V.	Netherlands	100	%
BeiGene NZ Unlimited	New Zealand	100	%
BeiGene Peru (Sociedad Comercial de Responsabilidad Limitada – S.R.L)	Peru	100	%
BeiGene Pharmaceuticals GmbH	Switzerland	100	%
BeiGene Pharmaceuticals (Guangzhou) Co., Ltd.	People’s Republic of China	100	%
BeiGene Pharmaceuticals Israel Ltd.	Israel	100	%
BeiGene Pharmaceutical (Shanghai) Co., Ltd.	People’s Republic of China	100	%
BeiGene Poland sp. z o.o.	Poland	100	%
BeiGene Portugal, Unipessoal Lda.	Portugal	100	%
BeiGene Shanghai	Cayman Islands	95	%
BeiGene Shanghai 101	Cayman Islands	95	%
BeiGene (Shanghai) Co., Ltd.	People’s Republic of China	100	%
BeiGene (Shanghai) Development Co., Ltd.	People’s Republic of China	95	%
BeiGene (Shanghai) Management Consulting Co., Ltd.	People’s Republic of China	100	%
BeiGene (Shanghai) Research & Development Co., Ltd.	People’s Republic of China	100	%
BeiGene Shanghai Asset Limited	Hong Kong	95	%
BeiGene Singapore Pte. Ltd.	Singapore	100	%

Exhibit 21

BeiGene South Africa Pty Ltd.	South Africa	100	%
BeiGene (Suzhou) Co., Ltd.	People’s Republic of China	100	%
BeiGene Sweden AB	Sweden	100	%
BeiGene Switzerland GmbH	Switzerland	100	%
BeiGene (Taiwan) Limited	Taiwan	100	%
BeiGene (Thailand) Ltd.	Thailand	100	%
BeiGene Turkey Medical Products Trade Limited Company	Turkey	100	%
BeiGene UK, Ltd.	United Kingdom	100	%
BeiGene United Kingdom, Ltd.	United Kingdom	100	%
BeiGene USA, Inc.	Delaware, United States	100	%
BeiGene US Holdings, LLC	Delaware, United States	100	%
BeiGene US Manufacturing Co., Inc.	Delaware, United States	100	%
Beijing Innerway Bio-tech Co., Ltd.	People’s Republic of China	100	%
Newco 101	Cayman Islands	100	%
Pi Health Aus Pty Ltd	Australia	100	%
Pi Health Brasil Consultoria Ltda.	Brazil	100	%
Pi Health Hong Kong Limited	Hong Kong	100	%
Pi Health, Ltd.	Cayman Islands	100	%
Pi Health Technologies Private Limited	India	100	%
Pi Health USA, LLC	Delaware, United States	100	%
SuGene Pharmaceuticals (Suzhou) Co., Ltd.	People’s Republic of China	100	%